dPmax test to predict RV failure after LVAD implantation
Official title: Predictive Value of dPmax Measured by Pulse Contour Analysis for Postoperative Right Ventricular Failure in Patients Undergoing LVAD Implantation
Run by Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital · NCT07918690 · Data updated 2026-11-12
A single-center study will see if dPmax, measured from arterial pressure data, can help predict right ventricular failure after LVAD surgery in adults.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 89 (estimated) |
| Sponsor | Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital Academic / other |
| Locations | 1 site (Ankara, Çankaya) |
| Status | Recruiting |
| Started | June 3, 2026 |
| Main results expected | September 2029 |
| Study ends | November 2029 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07918690 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) scheduled for LVAD implantation with available required clinical data and able to consent.
✕Probably not a fit
Patients in whom arterial waveform analysis cannot be reliably performed or who do not develop RV failure may not derive predictive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective observational study analyzes arterial pressure waveform data collected during routine care before and after anesthesia in adults scheduled for LVAD placement. Researchers will compare dPmax measurements with preoperative echo findings and the TAPSE/SPAP ratio to predict right ventricular failure within 30 days after surgery using MCS-ARC criteria. No extra invasive procedures are added for research beyond standard monitoring. The goal is to identify a dPmax threshold that best predicts RV failure and to gauge its predictive performance relative to existing measures.
Why it matters
Potential benefit: If successful, dPmax could improve early prediction of RV failure after LVAD, guiding perioperative planning and management.
How similar studies have gone: Similar hemodynamic waveform analyses have shown promise in predicting cardiac complications, but this specific dPmax approach for LVAD-related RV failure is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older. * Scheduled for left ventricular assist device (LVAD) implantation. * Availability of the clinical data required for the study. * Willingness and ability to provide informed consent. Exclusion Criteria: * Congenital heart disease associated with transposition of the great arteries. * Ongoing extracorporeal membrane oxygenation (ECMO) or extracorporeal ventricular assist device (ExVAD) support immediately before LVAD implantation. * Severe aortic regurgitation, severe peripheral arterial disease, or refractory and uncontrolled tachyarrhythmia that may interfere with arterial waveform analysis. * Unwillingness to participate or cognitive impairment preventing informed consent.
Where it's running
-
Ankara Bilkent City Hospital
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up
This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.
-
Right ventricular–arterial coupling during fluid loading in ICU patients
This study tests how the right ventricle handles fluid changes in critically ill adults to see how it affects blood flow and congestion.
-
Compare leadless and left bundle branch pacemakers for heart and valve function
This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.
-
Right-side heart function after pacemaker, ICD, or CRT implantation
This project will see if right heart function changes in adults getting a pacemaker, ICD, or CRT by comparing imaging and a blood test before the device and six months later.
-
Feasibility assessment of treatments for right ventricular failure
This study is testing if adding two different medications to standard care can help people with right heart failure and pulmonary hypertension feel better and if it's possible to do a bigger study in the future.
-
Using valsartan to help treat pulmonary hypertension
This study is testing if the medication valsartan can help adults with pulmonary arterial hypertension feel better and improve their heart function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.